Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry (CONFIRM2)

Cleerly

Status: Invitation-only

Conditions: Coronary Artery Disease

Study type: Observational

Funder types: Industry

Identifiers

NCT04279496

Confirm2-Registry

Details and patient eligibility

About

The overall objective of CONFIRM2 is to perform the largest cardiovascular phenotype outcomes study ever.

Full description

CONFIRM2 is a retrospective and prospective, open-label, international, multicenter observational registry designed to evaluate associations between CCTA imaging findings and clinical presentation (cross-sectional) and their ability to predict mortality and major adverse cardiac events (longitudinal) in patients with chronic CAD.

Enrollment: 35,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age >18 years
• Undergoing clinically indicated CCTA with >64-detector row CT
• Signed informed consent, including of release of medical information, long term follow-up and Health Insurance Portability and Accountability Act (HIPAA) documentation

Exclusion criteria

• Individuals unable to provide informed consent
• Non-cardiac illness with life expectancy < 2 years
• Pregnancy